2022
DOI: 10.21203/rs.3.rs-737437/v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Barriers to Mutational Testing in Patients with Gastrointestinal Stromal Tumors (GIST) – A Survey of Life Raft Group Members

Abstract: Background Due to the low mutational testing rate in patients with Gastrointestinal Stromal Tumors (GIST), The Life Raft Group (LRG), a non-profit organization that provides support, advocacy, and conducts research for patients with GIST, analyzed various factors that may have an impact on patients’ ability to receive mutational testing. Methods A survey about mutational testing for patients with GIST, or their caregivers, was conducted in June 2020. The survey, sent to 1004 GIST patients and care… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles